These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16150825)

  • 1. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].
    Cain WJ; Millar JS; Himebauch AS; Tietge UJ; Maugeais C; Usher D; Rader DJ
    J Lipid Res; 2005 Dec; 46(12):2681-91. PubMed ID: 16150825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
    Rosales C; Tang D; Gillard BK; Courtney HS; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1834-41. PubMed ID: 21597008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.
    Romagnuolo R; Scipione CA; Marcovina SM; Gemin M; Seidah NG; Boffa MB; Koschinsky ML
    PLoS One; 2017; 12(7):e0180869. PubMed ID: 28750079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
    Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG
    J Biol Chem; 1995 Dec; 270(48):28767-76. PubMed ID: 7499399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
    J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a].
    Fan J; Challah M; Shimoyamada H; Shiomi M; Marcovina S; Watanabe T
    J Lipid Res; 2000 Jun; 41(6):1004-12. PubMed ID: 10828093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
    Croyal M; Blanchard V; Ouguerram K; Chétiveaux M; Cabioch L; Moyon T; Billon-Crossouard S; Aguesse A; Bernardeau K; Le May C; Flet L; Lambert G; Hadjadj S; Cariou B; Krempf M; Nobécourt-Dupuy E
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):819-829. PubMed ID: 32078365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.
    Lindahl G; Mailly F; Humphries S; Seed M
    Clin Investig; 1994 Aug; 72(8):631-8. PubMed ID: 7819721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.
    Woollett LA; Osono Y; Herz J; Dietschy JM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12500-4. PubMed ID: 8618929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.
    Niemeier A; Willnow T; Dieplinger H; Jacobsen C; Meyer N; Hilpert J; Beisiegel U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):552-61. PubMed ID: 10073957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC; Jiang Y; Chen W; Cooper AD
    J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.